Clinical Trial Update: Cardiac Resynchronization Therapy in Congenital Heart Defects [Phase 2, Phase 3]

View source ↗

Summary

This document reports on the completion of Phase 2 and Phase 3 trials evaluating cardiac resynchronization therapy in patients with congenital heart defects. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects

Snippet

Sponsor: Competence Network for Congenital Heart Defects | Conditions: Congenital Heart Defects | Phase 2, Phase 3 | Status: COMPLETED